189 related articles for article (PubMed ID: 2016468)
1. Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury.
Willerson JT; Eidt JF; McNatt J; Yao SK; Golino P; Anderson HV; Buja LM
J Am Coll Cardiol; 1991 May; 17(6 Suppl B):101B-110B. PubMed ID: 2016468
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2 and serotonin mediate coronary blood flow reductions in unsedated dogs.
Eidt JF; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
Am J Physiol; 1989 Sep; 257(3 Pt 2):H873-82. PubMed ID: 2782444
[TBL] [Abstract][Full Text] [Related]
3. Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo.
Golino P; Buja LM; Yao SK; McNatt J; Willerson JT
J Am Coll Cardiol; 1990 Mar; 15(3):718-26. PubMed ID: 2105989
[TBL] [Abstract][Full Text] [Related]
4. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
[TBL] [Abstract][Full Text] [Related]
5. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury.
Willerson JT; Yao SK; McNatt J; Benedict CR; Anderson HV; Golino P; Murphree SS; Buja LM
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10624-8. PubMed ID: 1961728
[TBL] [Abstract][Full Text] [Related]
6. Insights into the role of thromboxane A2 and serotonin in the pathogenesis of unstable angina.
Machado AP; Saavedra JA; Ribeiro C
Rev Port Cardiol; 1994 Dec; 13(12):935-46, 893. PubMed ID: 7873224
[TBL] [Abstract][Full Text] [Related]
7. Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury.
Eidt JF; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
J Clin Invest; 1989 Aug; 84(2):517-27. PubMed ID: 2760199
[TBL] [Abstract][Full Text] [Related]
8. Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators.
Golino P; Ashton JH; Buja LM; Rosolowsky M; Taylor AL; McNatt J; Campbell WB; Willerson JT
Circulation; 1989 Jan; 79(1):154-66. PubMed ID: 2910540
[TBL] [Abstract][Full Text] [Related]
9. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
[TBL] [Abstract][Full Text] [Related]
10. Combined ADP and thromboxane A2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in nonhuman primates.
Yao SK; McNatt J; Cui K; Anderson HV; Maffrand JP; Buja LM; Willerson JT
Circulation; 1993 Dec; 88(6):2888-93. PubMed ID: 8252702
[TBL] [Abstract][Full Text] [Related]
11. Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products.
Willerson JT
Tex Heart Inst J; 1995; 22(1):13-9. PubMed ID: 7787465
[TBL] [Abstract][Full Text] [Related]
12. Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.
Ashton JH; Ogletree ML; Michel IM; Golino P; McNatt JM; Taylor AL; Raheja S; Schmitz J; Buja LM; Campbell WB
Circulation; 1987 Oct; 76(4):952-9. PubMed ID: 3652429
[TBL] [Abstract][Full Text] [Related]
13. Potential usefulness of combined thromboxane A2 and serotonin receptor blockade for preventing the conversion from chronic to acute coronary artery disease syndromes.
Willerson JT; Golino P; Eidt J; Yao SK; Buja LM
Am J Cardiol; 1990 Nov; 66(16):48G-53G. PubMed ID: 2146868
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina.
Eichhorn EJ; Grayburn PA; Willard JE; Anderson HV; Bedotto JB; Carry M; Kahn JK; Willerson JT
J Am Coll Cardiol; 1991 Jan; 17(1):43-52. PubMed ID: 1987239
[TBL] [Abstract][Full Text] [Related]
15. Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries.
Anderson HV; McNatt J; Clubb FJ; Herman M; Maffrand JP; DeClerck F; Ahn C; Buja LM; Willerson JT
Circulation; 2001 Nov; 104(19):2331-7. PubMed ID: 11696474
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
Ashton JH; Schmitz JM; Campbell WB; Ogletree ML; Raheja S; Taylor AL; Fitzgerald C; Buja LM; Willerson JT
Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
[TBL] [Abstract][Full Text] [Related]
17. Serotonin and thrombotic complications.
Willerson JT
J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S13-20. PubMed ID: 1717768
[TBL] [Abstract][Full Text] [Related]
18. Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries.
Ashton JH; Golino P; McNatt JM; Buja LM; Willerson JT
J Am Coll Cardiol; 1989 Mar; 13(3):755-63. PubMed ID: 2521875
[TBL] [Abstract][Full Text] [Related]
19. Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels.
Wright L; Homans DC; Laxson DD; Dai XZ; Bache RJ
J Am Coll Cardiol; 1992 Mar; 19(3):687-93. PubMed ID: 1538028
[TBL] [Abstract][Full Text] [Related]
20. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.
Willerson JT; Golino P; Eidt J; Campbell WB; Buja LM
Circulation; 1989 Jul; 80(1):198-205. PubMed ID: 2661053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
